292 related articles for article (PubMed ID: 26104564)
1. Use of Human Hybridoma Technology To Isolate Human Monoclonal Antibodies.
Smith SA; Crowe JE
Microbiol Spectr; 2015 Feb; 3(1):AID-0027-2014. PubMed ID: 26104564
[TBL] [Abstract][Full Text] [Related]
2. Hybridoma technologies for antibody production.
Tomita M; Tsumoto K
Immunotherapy; 2011 Mar; 3(3):371-80. PubMed ID: 21395379
[TBL] [Abstract][Full Text] [Related]
3. Preparation of human-mouse heterohybridomas against an immunising antigen.
Jessup CF; Baxendale H; Goldblatt D; Zola H
J Immunol Methods; 2000 Dec; 246(1-2):187-202. PubMed ID: 11121559
[TBL] [Abstract][Full Text] [Related]
4. Generation of Murine Monoclonal Antibodies by Hybridoma Technology.
Holzlöhner P; Hanack K
J Vis Exp; 2017 Jan; (119):. PubMed ID: 28117810
[TBL] [Abstract][Full Text] [Related]
5. Antigen-based immunofluorescence analysis of B-cell targeting: advanced technology for the generation of novel monoclonal antibodies with high efficiency and selectivity.
Tomita M; Fukuda T; Ozu A; Kimura K; Tsong TY; Yoshimura T
Hybridoma (Larchmt); 2006 Oct; 25(5):283-92. PubMed ID: 17044784
[TBL] [Abstract][Full Text] [Related]
6. Production of monoclonal antibodies.
Yokoyama WM; Christensen M; Santos GD; Miller D; Ho J; Wu T; Dziegelewski M; Neethling FA
Curr Protoc Immunol; 2013 Oct; 102():2.5.1-2.5.29. PubMed ID: 24510488
[TBL] [Abstract][Full Text] [Related]
7. [Attempts to improve hybridoma technology for the production of human monoclonal antibodies].
Tokunaga T; Chiba J; Ohnishi K
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2198-204. PubMed ID: 3038035
[TBL] [Abstract][Full Text] [Related]
8. Antibody producing human-human hybridomas. I. Technical aspects.
Olsson L; Kronstrøm H; Cambon-De Mouzon A; Honsik C; Brodin T; Jakobsen B
J Immunol Methods; 1983 Jun; 61(1):17-32. PubMed ID: 6343505
[TBL] [Abstract][Full Text] [Related]
9. Electric field-induced cell fusion and human monoclonal antibodies.
Foung SK; Perkins S
J Immunol Methods; 1989 Jan; 116(1):117-22. PubMed ID: 2536773
[TBL] [Abstract][Full Text] [Related]
10. High-resolution analysis of the B cell repertoire before and after polyethylene glycol fusion reveals preferential fusion of rare antigen-specific B cells.
Dubois AR; Buerckert JP; Sinner R; Faison WJ; Molitor AM; Muller CP
Hum Antibodies; 2016 Jun; 24(1-2):1-15. PubMed ID: 27472868
[TBL] [Abstract][Full Text] [Related]
11. Development and application of a modified monoclonal hybridoma technique for isolating monoclonal antibodies to human brain regions.
Fukuyama R; Brady DR; Rapoport SI
J Neurosci Methods; 1996 Jan; 64(1):135. PubMed ID: 8869493
[TBL] [Abstract][Full Text] [Related]
12. Hybridoma Technology.
Hnasko RM; Stanker LH
Methods Mol Biol; 2015; 1318():15-28. PubMed ID: 26160560
[TBL] [Abstract][Full Text] [Related]
13. [Human hybridoma neutralizing antibodies to the herpes simplex virus].
Kushch AA; Tugizov ShM; Terletskaia EN; Posevaia TA; Nikitina AA; L'vov ND; Barinskiĭ IF
Vopr Virusol; 1992; 37(5-6):264-6. PubMed ID: 1337804
[TBL] [Abstract][Full Text] [Related]
14. In vitro stimulation prior to fusion generates antigen-binding human-human hybridomas.
Wasserman RL; Budens RD; Thaxton ES
J Immunol Methods; 1986 Nov; 93(2):275-83. PubMed ID: 3534099
[TBL] [Abstract][Full Text] [Related]
15. Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanoma.
Houghton AN; Brooks H; Cote RJ; Taormina MC; Oettgen HF; Old LJ
J Exp Med; 1983 Jul; 158(1):53-65. PubMed ID: 6864164
[TBL] [Abstract][Full Text] [Related]
16. [Monoclonal antibodies produced by human-human hybridomas].
Chida J
Gan To Kagaku Ryoho; 1984 Jan; 11(1):157-64. PubMed ID: 6607711
[TBL] [Abstract][Full Text] [Related]
17. Efficient generation of stable antibody forming hybridoma cells by electrofusion.
Schmitt JJ; Zimmermann U; Neil GA
Hybridoma; 1989 Feb; 8(1):107-15. PubMed ID: 2925206
[TBL] [Abstract][Full Text] [Related]
18. Study on rat-rat hybridoma technique and production of rat monoclonal antibodies against HIV and HBsAg.
Fang JC; Bodeus M; Burtonboy G
Chin J Biotechnol; 1991; 7(1):73-81. PubMed ID: 1773018
[TBL] [Abstract][Full Text] [Related]
19. Fusion of myeloma cells with immune spleen cells.
Fuller SA; Takahashi M; Hurrell JG
Curr Protoc Mol Biol; 2001 May; Chapter 11():Unit11.7. PubMed ID: 18265079
[TBL] [Abstract][Full Text] [Related]
20. Antibody engineering, a strategy for the development of monoclonal antibodies.
Schönherr OT; Houwink EH
Antonie Van Leeuwenhoek; 1984; 50(5-6):597-623. PubMed ID: 6099095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
